Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 USD | -6.05% | -8.97% | -45.90% |
05-15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
05-14 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.90% | 130M | |
+11.18% | 225B | |
+15.22% | 197B | |
+19.19% | 143B | |
+30.89% | 111B | |
+2.62% | 64.72B | |
+18.48% | 54.44B | |
+5.12% | 51.06B | |
+10.53% | 45.03B | |
+5.98% | 37.4B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Morgan Stanley Trims Akoya Biosciences Price Target to $18 From $19, Maintains Overweight Rating